ENTX Insider Trading

Insider Ownership Percentage: 8.90%
Insider Buying (Last 12 Months): $56,274.47
Insider Selling (Last 12 Months): $0.00

Entera Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Entera Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Entera Bio Share Price & Price History

Current Price: $2.22
Price Change: Price Decrease of -0.07 (-3.06%)
As of 04/17/2024 01:00 AM ET

This chart shows the closing price history over time for ENTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Entera Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/12/2024Haya TaitelDirectorBuy9,500$0.99$9,405.0035,115View SEC Filing Icon  
1/10/2024Haya TaitelDirectorBuy7,615$0.77$5,863.5525,615View SEC Filing Icon  
12/22/2023Miranda Jayne ToledanoCEOBuy23,952$0.71$17,005.92110,752View SEC Filing Icon  
8/21/2023Sean EllisDirectorBuy40,000$0.60$24,000.00102,100View SEC Filing Icon  
4/4/2023Miranda Jayne ToledanoCEOBuy30,000$1.01$30,300.0086,800View SEC Filing Icon  
11/11/2022Miranda Jayne ToledanoCEOBuy50,000$0.53$26,500.0056,800View SEC Filing Icon  
11/11/2022Sean EllisDirectorBuy30,000$0.53$15,900.0062,100View SEC Filing Icon  
7/21/2022Sean EllisDirectorBuy14,900$1.64$24,436.0032,100View SEC Filing Icon  
1/19/2022Ramesh RatanCFOBuy10,000$2.44$24,400.00View SEC Filing Icon  
1/18/2022Ron MayronDirectorBuy7,000$2.80$19,600.00View SEC Filing Icon  
1/13/2022Yonatan MalcaDirectorBuy7,232$2.74$19,815.68View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Entera Bio (NASDAQ:ENTX)

14.11% of Entera Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ENTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Entera Bio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2023Millennium Management LLC46,000$34K0.0%+358.5%0.160%Search for SEC Filing on Google Icon
2/14/2023RA Capital Management L.P.295,966$0.22M0.0%-85.8%1.028%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC139,600$0.10M0.0%+555.4%0.485%Search for SEC Filing on Google Icon
11/14/2022RA Capital Management L.P.2,082,372$2.17M0.0%-11.5%7.229%Search for SEC Filing on Google Icon
5/12/2022PNC Financial Services Group Inc.10,000$29K0.0%N/A0.042%Search for SEC Filing on Google Icon
1/31/2022Altium Wealth Management LLC11,830$33K0.0%N/A0.050%Search for SEC Filing on Google Icon
1/28/2022ARK Investment Management LLC690,922$1.95M0.0%+1.2%2.915%Search for SEC Filing on Google Icon
8/17/2021Knoll Capital Management LLC2,484,275$14.86M7.8%+38.7%10.482%Search for SEC Filing on Google Icon
8/16/2021RA Capital Management L.P.2,353,000$14.07M0.2%N/A9.928%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC17,597$0.11M0.0%N/A0.074%Search for SEC Filing on Google Icon
8/11/2021Susquehanna Fundamental Investments LLC14,400$86K0.0%N/A0.061%Search for SEC Filing on Google Icon
6/14/2021Knoll Capital Management LLC1,791,363$6.83M4.4%+2.9%7.558%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC38,611$0.15M0.0%N/A0.163%Search for SEC Filing on Google Icon
5/14/2021XTX Topco Ltd11,559$44K0.0%N/A0.101%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC120,407$0.46M0.0%+66.8%1.053%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC31,314$34K0.0%N/A0.274%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC72,186$78K0.0%N/A0.632%Search for SEC Filing on Google Icon
10/20/2020Wedbush Securities Inc.121,616$0.15M0.0%+305.3%1.064%Search for SEC Filing on Google Icon
8/10/2020Phoenix Holdings Ltd.37,400$66K0.0%-46.1%0.000%Search for SEC Filing on Google Icon
7/16/2020Wedbush Securities Inc.30,008$55K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/20/2020Phoenix Holdings Ltd.69,355$0.14M0.0%N/A0.607%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Entera Bio logo
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. Its other product candidate is GLP-2, which is in preclinical trial for the treatment of short bowl syndrome; and hGh for the GH deficiency. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
Read More on Entera Bio

Today's Range

Now: $2.22
Low: $2.06
High: $2.27

50 Day Range

MA: $1.53
Low: $0.84
High: $2.98

52 Week Range

Now: $2.22
Low: $0.52
High: $3.35

Volume

209,349 shs

Average Volume

479,382 shs

Market Capitalization

$63.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7

Who are the company insiders with the largest holdings of Entera Bio?

Entera Bio's top insider shareholders include:
  1. Miranda Jayne Toledano (CEO)
  2. Sean Ellis (Director)
  3. Haya Taitel (Director)
Learn More about top insider investors at Entera Bio.